A 28-year-old woman with HIV/AIDS (CD4 count 45 cells/μL) presents with fever, cough, and dyspnea. Sputum smear microscopy is negative for acid-fast bacilli on two occasions. Chest X-ray shows bilateral interstitial infiltrates. Clinical suspicion for TB remains high. Which investigation is most appropriate to establish TB diagnosis in this immunocompromised patient?

Explanation

## Investigation of Choice in Smear-Negative, Immunocompromised TB **Key Point:** GeneXpert MTB/RIF (Xpert MTB/RIF) is the WHO-recommended rapid molecular test for TB diagnosis in smear-negative cases, especially in HIV-positive patients with low CD4 counts. It detects TB DNA and rifampicin resistance simultaneously within 2 hours. ### Why GeneXpert MTB/RIF in This Scenario? **High-Yield:** In severely immunocompromised patients (CD4 < 50 cells/μL): - Sputum smear microscopy has **low sensitivity (~30–40%)** due to minimal inflammatory response and low bacillary load - TB may be present in extrapulmonary sites (lymph nodes, blood, CSF) - Rapid diagnosis is critical to initiate TB-HIV co-treatment early - GeneXpert MTB/RIF sensitivity is **95–98%** even in smear-negative cases | Investigation | Sensitivity (CD4 < 50) | Time to Result | Detects Resistance | Use in HIV+ | |---|---|---|---|---| | Sputum smear microscopy | 30–40% | 1 day | No | Low | | GeneXpert MTB/RIF | 95–98% | 2 hours | RIF resistance only | **Recommended** | | Sputum culture | 80–90% | 2–8 weeks | Yes (full DST) | Yes, but slow | | TST | <5% (anergic) | 48–72 hours | No | Not reliable | **Clinical Pearl:** In HIV+ patients with CD4 < 100 cells/μL, TB-HIV co-infection mortality is high if TB diagnosis is delayed. GeneXpert MTB/RIF enables same-day diagnosis and rapid initiation of therapy. **Mnemonic — Diagnostic Approach in Smear-Negative TB:** **GRAM** - **G**eneXpert MTB/RIF → first-line rapid test - **R**epeat smear (fluorescent microscopy) → if GeneXpert unavailable - **A**dvanced imaging (HRCT) → assess extent - **M**olecular/culture → confirm and get DST **Warning:** TST is unreliable in CD4 < 200 cells/μL due to anergy (cutaneous immune suppression). A negative TST does NOT exclude TB in this patient. [cite:Harrison 21e Ch 165; WHO TB Guidelines 2023]